genomics market is expected to generate USD 41.2 bn by 2025, at a CAGR of 14.2% between 2019 & 2025. The global genomics market has been split into deliverables

FLORIDA, UNITED STATES, October 3, 2022 /EINPresswire.com/ -- Zion Market Research has published a new report titled “Genomics Market by Deliverables (Services and Products), by Application (Epigenomics, Functional, Biomarker Discovery, Pathway Analysis, and Others), and by End-User (Government and Academic Institutes, Clinical Research, Biotechnology, and Pharmaceutical Companies, Hospitals and Clinics, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, the global genomics market was valued at approximately USD 16.4 billion in 2018 and is expected to generate around USD 41.2 billion by 2025, at a CAGR of 14.2% between 2019 and 2025.

The increasing number of research projects in genomics, diminishing sequencing cost, expanding applications of genomics, escalating demand for nucleic acid sequencing, rising research and development activity in drug discovery and molecular biology, market growth initiatives taken by public and private organizations, entry of start-ups in genomics, and rising genomics support in advance of tailored medicines are major factors driving the global genomics market. The popularization of collaborations between research institutes and companies and the rising preference for personalized medicine is likely to offer new growth opportunities to the players in the global genomics market. However, the dearth of skilled professionals, high equipment costs required in genomics, and the lack of awareness may restrict the global genomics market in the years ahead.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐚 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭@https://www.zionmarketresearch.com/sample/genomics-market

The global genomics market has been split into deliverables, applications, and end users. Based on deliverables, the genomics market includes services and products. The products segment is expected to dominate the market over the estimated time period, majorly due to the recurrent use of instruments and reagents for genomics research and the rising number of research programs undertaken by government and private organizations. The services segment is sub-segmented into NGS-based, core genomics, computational, biomarker translation, and others. Products are sub-segmented into reagents and instruments. The application segment includes epigenomics, functional, biomarker discovery, pathway analysis, and others. Functional division dominated the application segment in 2018, due to a huge volume of sequencing data generation. Epigenomics is sub-segmented into chromatin immunoprecipitation (ChIP-Seq), bisulfite sequencing, methylated DNA immunoprecipitation (MeDIP), chromatin accessibility assays, high-resolution melt (HRM), and microarray analysis.

Functionality is sub-segmented into real-time PCR, transfection, RNA interference, SNP analysis, mutational analysis, and microarray analysis. Biomarker discovery is sub-segmented into real-time PCR, mass spectrometry, microarray analysis, genomics, statistical analysis, and DNA sequencing. Pathway analysis is sub-segmented into microarray analysis, bead-based analysis, real-time PCR, and proteomics tools.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧 𝐨𝐧 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭

The end-user segment includes government and academic institutes, clinical research, biotechnology and pharmaceutical companies, hospitals and clinics, and others. Biotechnology and pharmaceutical companies are expected to dominate the market, due to the increasing number of genetic research training.

North America will lead in the future and account for over 38% of the global genomics market in 2018. Continuous funding for life sciences research from private organizations and government institutions, growing implementation of tailored medicines, increasing investments made by academic institutions in genomics research, the presence of state-of-the-art healthcare facilities, and early adoption of the latest technologies are boosting the North American market. Europe will be the second largest market in the future, owing to the presence of skilled researchers, high R&D investments made by leading companies, increasing geriatric population, the rising prevalence of chronic disorders, and positive reimbursement scenario. The Asia Pacific market will propagate speedily over the forecast time period, due to the rising incidences of chronic diseases, growing interest in genomics, increasing research and development on genomics applications, and escalating use of genomics in disease diagnosis.

Some key players in the global genomics market are Illumina, Inc., Thermo Fisher Scientific, Inc., QIAGEN N.V., Eurofins Scientific, Agilent Technologies, Inc., GE Healthcare, BGI, Bio-Rad Laboratories, Inc., Oxford Nanopore Technologies, and F. Hoffmann-La Roche Ltd.

Browse the full “𝐆𝐞𝐧𝐨𝐦𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐛𝐲 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐚𝐛𝐥𝐞𝐬 (𝐒𝐞𝐫𝐯𝐢𝐜𝐞𝐬 𝐚𝐧𝐝 𝐏𝐫𝐨𝐝𝐮𝐜𝐭𝐬), 𝐛𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 (𝐄𝐩𝐢𝐠𝐞𝐧𝐨𝐦𝐢𝐜𝐬, 𝐅𝐮𝐧𝐜𝐭𝐢𝐨𝐧𝐚𝐥, 𝐁𝐢𝐨𝐦𝐚𝐫𝐤𝐞𝐫 𝐃𝐢𝐬𝐜𝐨𝐯𝐞𝐫𝐲, 𝐏𝐚𝐭𝐡𝐰𝐚𝐲 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬, 𝐚𝐧𝐝 𝐎𝐭𝐡𝐞𝐫𝐬), 𝐚𝐧𝐝 𝐛𝐲 𝐄𝐧𝐝-𝐔𝐬𝐞𝐫 (𝐆𝐨𝐯𝐞𝐫𝐧𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐀𝐜𝐚𝐝𝐞𝐦𝐢𝐜 𝐈𝐧𝐬𝐭𝐢𝐭𝐮𝐭𝐞𝐬, 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡, 𝐁𝐢𝐨𝐭𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐚𝐧𝐝 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬, 𝐇𝐨𝐬𝐩𝐢𝐭𝐚𝐥𝐬 𝐚𝐧𝐝 𝐂𝐥𝐢𝐧𝐢𝐜𝐬, 𝐚𝐧𝐝 𝐎𝐭𝐡𝐞𝐫𝐬): 𝐆𝐥𝐨𝐛𝐚𝐥 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐏𝐞𝐫𝐬𝐩𝐞𝐜𝐭𝐢𝐯𝐞, 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬, 𝐚𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭, 𝟐𝟎𝟏𝟖–𝟐𝟎𝟐𝟓” 𝐑𝐞𝐩𝐨𝐫𝐭 𝐚𝐭

https://www.zionmarketresearch.com/report/genomics-market

𝐓𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐠𝐞𝐧𝐨𝐦𝐢𝐜𝐬 𝐦𝐚𝐫𝐤𝐞𝐭 𝐚𝐬 𝐟𝐨𝐥𝐥𝐨𝐰𝐬:

𝐆𝐥𝐨𝐛𝐚𝐥 𝐆𝐞𝐧𝐨𝐦𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐁𝐲 𝐃𝐞𝐥𝐢𝐯𝐞𝐫𝐚𝐛𝐥𝐞𝐬

Services
NGS-Based
Core Genomics
Computational
Biomarker Translation
Others
Products
Reagents
Instruments

𝐆𝐥𝐨𝐛𝐚𝐥 𝐆𝐞𝐧𝐨𝐦𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐁𝐲 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧

Epigenomics
Chromatin Immunoprecipitation (ChIP-Seq)
Bisulfite Sequencing
Methylated DNA Immunoprecipitation (MeDIP)
Chromatin Accessibility Assays
High-Resolution Melt (HRM)
Microarray Analysis
Functional
Real-Time PCR
Transfection
RNA Interference
SNP Analysis
Mutational Analysis
Microarray Analysis
Biomarker Discovery
Real-Time PCR
Mass Spectrometry
Microarray Analysis
Bioinformatics
Statistical Analysis
DNA Sequencing
Pathway Analysis
Microarray Analysis
Bead-Based Analysis
Real-Time PCR
Proteomics Tools
Others

𝐆𝐥𝐨𝐛𝐚𝐥 𝐆𝐞𝐧𝐨𝐦𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐁𝐲 𝐄𝐧𝐝-𝐔𝐬𝐞𝐫

Government and Academic Institutes
Clinical Research
Biotechnology and Pharmaceutical Companies
Hospitals and Clinics
Others

𝐆𝐥𝐨𝐛𝐚𝐥 𝐆𝐞𝐧𝐨𝐦𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐁𝐲 𝐑𝐞𝐠𝐢𝐨𝐧

North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
The Middle East and Africa

𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭𝐬
Digital Genome Market
https://www.zionmarketresearch.com/news/digital-genome-market

𝐆𝐞𝐧𝐨𝐦𝐢𝐜𝐬 𝐌𝐚𝐫𝐤𝐞𝐭
https://www.zionmarketresearch.com/news/genomics-market

Kajal Rupnar
Zion Market Research
+ +18554654651 ext.
kajal.r@marketresearchstore.com
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.